drugset / Trial / NCT04338477

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

NCT04338477 ↗

Phase 3 Completed 66 enrolled A. Vogel AG
NaSingle-groupOpen-labelOther

Summary

Fluid intake and urinary output are measured with /without intake of Nephrosolid tablets in acute ( 1 day application ) and chronic ( 28 days application) therapy.

Timeline

Start
2018-02-12
Primary completion
2018-12-17
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nephrosolid Unknown 1 unknown —

Indications

No indication recorded.